Volume 16, Issue 2 (9-2018)                   sjsph 2018, 16(2): 180-195 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadsadeghi M, Mohammadzadeh Honarvar N, Qorbani M, Mansouri A, Kouhdani F. The Effect of Docosahexaenoic Acid on Serum Levels of Apolipoproteins in Patients with Type-2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. sjsph. 2018; 16 (2) :180-195
URL: http://sjsph.tums.ac.ir/article-1-5647-en.html
1- MSPH. Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
2- Ph.D. Assistant Professor, Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
3- Ph.D. Assistant Professor, Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
4- Ph.D. Assistant Professor, Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5- Ph.D. Professor, Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Diabetes Research Center, Endocrinology
Abstract:   (115 Views)
Background and Aim: Lipoprotein disorders are an integral component of type-2 diabetes mellitus (T2DM). Therefore, early diagnosis and treatment of lipid disorders can be beneficial in prevention and treatment of many complications associated with T2DM.The aim of this study wasto determine the effect of docosahexaenoic acid (DHA) supplementation on the serum levels of apolipoproteins (Apos) A1, A2, B48 and C3 in patients withT2DM.
Materials and Methods: In this 8-week randomized, double-blind, placebo-controlled clinical trial, 44 T2DMpatients were randomly assigned to either an experimental group (n=22, receiving daily 2.4 g DHA) or a placebo group (n = 22, receiving paraffin). The serum levels of AposA1, A2, B48 and C3 were measured in all the patients at the beginning and at the end of the period.
Results: There was a statistically significant increase in the mean serum level of ApoA1 in the DHA group (p = 0.014). In addition, a significant difference was observed in the serum level of ApoC3 after intervention between the DHA and placebo group (p=0.031). There were no significant differences between the two groups as regards the mean changes in serum levels of ApoA1, ApoA2, ApoB48 and ApoC3.
Conclusions: Dietary supplementation with docosahexaenoic acidhasno effects on the serum levels of apolipoproteins in patients with type-2 diabetes.
Full-Text [PDF 892 kb]   (27 Downloads)    
Type of Study: Research | Subject: Public Health
Received: 2018/09/18 | Accepted: 2018/09/18 | Published: 2018/09/18

Add your comments about this article : Your username or Email:
CAPTCHA code

© 2018 All Rights Reserved | Journal of School of Public Health and Institute of Public Health Research

Designed & Developed by : Yektaweb